Tidemark’s Takeda Pharmaceutical TAK Stock Holding History

Tidemark’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.02K	Hold	126	–	–	﹤0.01%	691
2026 Q1	$2.33K	Hold	126	–	–	﹤0.01%	641
2025 Q4	$1.96K	Hold	126	–	–	﹤0.01%	578
2025 Q3	$1.84K	Hold	126	–	–	﹤0.01%	604
2025 Q2	$1.95K	Hold	126	–	–	﹤0.01%	603
2025 Q1	$1.87K	Hold	126	–	–	﹤0.01%	620
2024 Q4	$1.67K	Hold	126	–	–	﹤0.01%	598
2024 Q3	$1.79K	Hold	126	–	–	﹤0.01%	560
2024 Q2	$1.63K	Hold	126	–	–	﹤0.01%	540
2024 Q1	$1.75K	Hold	126	–	–	﹤0.01%	609
2023 Q4	$1.8K	Buy	+126	New	+$1.79K	﹤0.01%	607

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Tidemark's TAK Position: Q2 2026 in Review

Tidemark held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 126 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Tidemark first reported a position in TAK in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.33K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Tidemark held 126 shares of Takeda Pharmaceutical worth $2.02K as of Q2 2026.
Tidemark left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #691 holding.
Tidemark first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
Tidemark's Takeda Pharmaceutical position peaked at $2.33K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.